The company’s third-quarter earnings report for fiscal 2024 showed strong sales growth and adjusted per-share earnings of ...

I had high expectations for Boston Scientific going into 2024 – at ... and other less-celebrated businesses like urology and peripheral vascular continue to perform well. As far as dangers ...

Bolt Acquisition Deal Drives BSX Stock Close to 52-Week High Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

The company primarily operates through its MedSurg (endoscopy, urology, and neuromodulation ... a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp ...

In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI ...

Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

Boston Scientific closes the year at historic highs ... growth stands at 10% led by strong sales of ELUVIA™ system. The Urology segment reports a 12% rise due to the success of the Rezūm ...

Travis Steed, an analyst from Bank of America Securities, maintained the Buy rating on Intuitive Surgical (ISRG – Research Report). The ...